Circulating tumour DNA to evaluate response in children with neuroblastoma Presented ByDr Kevin Campbell, Dana-Farber Cancer Institute, MA, USA TrialPhase 2, NANT2011-01 ConferenceASCO 2021 12 August, 2021 22:50